BG Medicine's Enterprise Value for the quarter that ended in Dec. 2015 was $2.66 Mil.
BG Medicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2015 was $-5.14 Mil. BG Medicine's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2015 was -192.31%.
The historical rank and industry rank for BG Medicine's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
BGMD's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.19 * Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. BG Medicine's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2015 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
BG Medicine Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for BG Medicine's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
BG Medicine Annual Data
Trend
Dec05
Dec06
Dec08
Dec09
Dec10
Dec11
Dec12
Dec13
Dec14
Dec15
Earnings Yield (Joel Greenblatt) %
-24.88
-51.02
-51.28
-49.75
-192.31
BG Medicine Quarterly Data
Mar11
Jun11
Sep11
Dec11
Mar12
Jun12
Sep12
Dec12
Mar13
Jun13
Sep13
Dec13
Mar14
Jun14
Sep14
Dec14
Mar15
Jun15
Sep15
Dec15
Earnings Yield (Joel Greenblatt) %
-49.75
-23.53
-32.36
-285.71
-192.31
Competitive Comparison
For the Medical Instruments & Supplies subindustry, BG Medicine's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BG Medicine Earnings Yield (Joel Greenblatt) % Distribution
For the Medical Devices & Instruments industry and Healthcare sector, BG Medicine's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where BG Medicine's Earnings Yield (Joel Greenblatt) % falls into.
BG Medicine Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
BG Medicines Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2015 is calculated as
BG Medicine's EBIT for the trailing twelve months (TTM) ended in Dec. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.14 Mil.
BG Medicine (OTCPK:BGMD) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
BG Medicine Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of BG Medicine's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BGMD has been successfully added to your 